Divi's Laboratories Limited (DIVISLAB.NS)
INR 5589.3
(3.77%)
INR 5589.3
(3.77%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -39.77 Billion INR | -2289.45% |
| 2022 | -1.66 Billion INR | 86.26% |
| 2021 | -12.11 Billion INR | 40.21% |
| 2020 | -20.25 Billion INR | -47004.42% |
| 2019 | -43 Million INR | -104.64% |
| 2018 | 926 Million INR | 143.94% |
| 2017 | 379.6 Million INR | 153.89% |
| 2016 | 149.51 Million INR | 155.96% |
| 2015 | -267.19 Million INR | -436.06% |
| 2014 | 79.5 Million INR | 344.62% |
| 2013 | 17.88 Million INR | -90.58% |
| 2012 | 189.85 Million INR | -13.01% |
| 2011 | 218.25 Million INR | 306.21% |
| 2010 | 53.72 Million INR | -67.21% |
| 2009 | 163.87 Million INR | -91.8% |
| 2008 | 1.99 Billion INR | 178.16% |
| 2007 | 718.73 Million INR | -47.0% |
| 2006 | 1.35 Billion INR | -2.9% |
| 2005 | 1.39 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 36.98 Billion INR | 192.98% |
| 2023 Q3 | -39.77 Billion INR | -210.14% |
| 2023 Q2 | 36.11 Billion INR | 12136.67% |
| 2023 Q1 | -300 Million INR | -100.73% |
| 2023 FY | -39.77 Billion INR | -2289.45% |
| 2022 Q2 | 33.36 Billion INR | 1451.52% |
| 2022 Q3 | -1.66 Billion INR | -104.99% |
| 2022 Q4 | 41.32 Billion INR | 2582.79% |
| 2022 FY | -1.66 Billion INR | 86.26% |
| 2022 Q1 | -2.46 Billion INR | -109.0% |
| 2021 Q4 | 27.41 Billion INR | 326.38% |
| 2021 Q3 | -12.11 Billion INR | -164.43% |
| 2021 Q2 | 18.79 Billion INR | 206.89% |
| 2021 FY | -12.11 Billion INR | 40.21% |
| 2021 Q1 | -17.58 Billion INR | -184.35% |
| 2020 Q1 | -17.41 Billion INR | -259.19% |
| 2020 FY | -20.25 Billion INR | -47004.42% |
| 2020 Q2 | 18.69 Billion INR | 207.32% |
| 2020 Q3 | -20.25 Billion INR | -208.37% |
| 2020 Q4 | 20.84 Billion INR | 202.94% |
| 2019 Q3 | -43 Million INR | -100.75% |
| 2019 Q1 | -417.8 Million INR | -102.96% |
| 2019 FY | -43 Million INR | -104.64% |
| 2019 Q4 | 10.93 Billion INR | 25541.4% |
| 2019 Q2 | 5.77 Billion INR | 1481.09% |
| 2018 Q3 | 926 Million INR | 0.0% |
| 2018 FY | 926 Million INR | 143.94% |
| 2018 Q4 | 14.11 Billion INR | 1424.13% |
| 2017 FY | 379.6 Million INR | 153.89% |
| 2017 Q4 | 19.14 Billion INR | 0.0% |
| 2016 FY | 149.51 Million INR | 155.96% |
| 2015 FY | -267.19 Million INR | -436.06% |
| 2014 Q3 | -391 Million INR | 0.0% |
| 2014 FY | 79.5 Million INR | 344.62% |
| 2013 FY | 17.88 Million INR | -90.58% |
| 2013 Q3 | -226.3 Million INR | 0.0% |
| 2012 Q3 | -82.8 Million INR | 0.0% |
| 2012 FY | 189.85 Million INR | -13.01% |
| 2011 FY | 218.25 Million INR | 306.21% |
| 2010 FY | 53.72 Million INR | -67.21% |
| 2009 FY | 163.87 Million INR | -91.8% |
| 2008 FY | 1.99 Billion INR | 178.16% |
| 2007 FY | 718.73 Million INR | -47.0% |
| 2006 FY | 1.35 Billion INR | -2.9% |
| 2005 FY | 1.39 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 1128.738% |
| Hester Biosciences Limited | 2.29 Billion INR | 1836.12% |
| Aarti Drugs Limited | 5.54 Billion INR | 816.783% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 1622.646% |
| Albert David Limited | -278.36 Million INR | -14186.792% |
| Alembic Limited | 66.9 Million INR | 59546.936% |
| Alkem Laboratories Limited | -1.6 Billion INR | -2371.107% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | 17396.343% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 1305.533% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -215502.299% |
| Brooks Laboratories Limited | 49.48 Million INR | 80467.788% |
| Eris Lifesciences Limited | 13.8 Billion INR | 388.055% |
| FDC Limited | -57.75 Million INR | -68763.416% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | -1299.042% |
| Gufic Biosciences Limited | 3.19 Billion INR | 1345.024% |
| Hikal Limited | 7.96 Billion INR | 599.184% |
| Ind-Swift Limited | 9.5 Billion INR | 518.253% |
| Innova Captab Limited | 2.33 Billion INR | 1804.117% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | -3511.187% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | -2761.295% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 246.905% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | -31058.432% |
| Lupin Limited | 19.38 Billion INR | 305.16% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 4175.584% |
| Medico Remedies Limited | 78.67 Million INR | 50648.445% |
| Morepen Laboratories Limited | -231.17 Million INR | -17103.492% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 745.9% |
| Orchid Pharma Limited | -1.31 Billion INR | -2926.993% |
| Procter & Gamble Health Limited | -2.34 Billion INR | -1593.782% |
| RPG Life Sciences Limited | -364.7 Million INR | -10804.853% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 33230.899% |
| Sigachi Industries Limited | 859.94 Million INR | 4724.693% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 496.439% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 27532.127% |
| Themis Medicare Limited | 764.96 Million INR | 5298.951% |
| Unichem Laboratories Limited | 931.91 Million INR | 4367.552% |
| Vaishali Pharma Limited | 119.13 Million INR | 33482.297% |
| Wanbury Limited | 1.1 Billion INR | 3696.247% |
| Windlas Biotech Limited | -273.04 Million INR | -14465.631% |
| ZIM Laboratories Limited | 983.6 Million INR | 4143.294% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | -857.608% |
| Ipca Laboratories Limited | 11.41 Billion INR | 448.395% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 45.122% |
| Venus Remedies Limited | -267.7 Million INR | -14756.182% |
| Sakar Healthcare Limited | 790.93 Million INR | 5128.213% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 1176.815% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | -693.426% |
| Mankind Pharma Limited | -1.74 Billion INR | -2174.715% |
| Sequent Scientific Limited | 4.17 Billion INR | 1051.747% |
| Laurus Labs Limited | 24.35 Billion INR | 263.276% |
| Neuland Laboratories Limited | -214.05 Million INR | -18479.077% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 1509.684% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | -828.065% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 1116.616% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -15885.241% |
| Wockhardt Limited | 18.27 Billion INR | 317.679% |
| Bal Pharma Limited | 1.26 Billion INR | 3247.454% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 407.984% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | -3335.105% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | -10750.141% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | -622.08% |
| Shilpa Medicare Limited | 9.06 Billion INR | 538.501% |
| Valiant Laboratories Limited | 649.9 Million INR | 6219.384% |
| Ajanta Pharma Limited | -954.9 Million INR | -4064.834% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | 13464.507% |
| Granules India Limited | 9.28 Billion INR | 528.243% |
| Medicamen Biotech Limited | 160.31 Million INR | 24907.256% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 86161.76% |
| Piramal Enterprises Limited | 491.39 Billion INR | 108.093% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 224.945% |
| NATCO Pharma Limited | -5.81 Billion INR | -583.686% |
| Suven Life Sciences Limited | -1.63 Billion INR | -2335.845% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 2157.508% |
| Strides Pharma Science Limited | 23.25 Billion INR | 271.002% |
| Indoco Remedies Limited | 6.47 Billion INR | 714.085% |
| Alpa Laboratories Limited | 35.36 Million INR | 112562.178% |
| Lasa Supergenerics Limited | 205.79 Million INR | 19424.681% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | -4122.765% |